A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis
Marine Drugs · 2023
DOI: 10.3390/md21100517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Nannan Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China. Hauptthemen laut MEDLINE: Neoplasms, Sirtuins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Program of National Natural Science Foundation of China, the Program of Shandong Province Special Fund "Frontier Technology and Free Exploration" Project of Laoshan Laboratory, the Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Angiogenesis refers to the process of growing new blood vessels from pre-existing capillaries or post-capillary veins. This process plays a critical role in promoting tumorigenesis and metastasis. As a result, developing antiangiogenic agents has become an attractive strategy for tumor treatment. Sirtuin6 (SIRT6), a member of nicotinamide adenine (NAD+)-dependent histone deacetylases, regulates various biological processes, including metabolism, oxidative stress, angiogenesis, and DNA damage and repair. Some SIRT6 inhibitors have been identified, but the effects of SIRT6 inhibitors on anti-angiogenesis have not been reported. We have identified a pyrrole-pyridinimidazole derivative 8a as a highly effective inhibitor of SIRT6 and clarified its anti-pancreatic-cancer roles. This study investigated the antiangiogenic roles of 8a. We found that 8a was able to inhibit the migration and tube formation of HUVECs and downregulate the expression of angiogenesis-related proteins, including VEGF, HIF-1α, p-VEGFR2, and N-cadherin, and suppress the activation of AKT and ERK pathways. Additionally, 8a significantly blocked angiogenesis in intersegmental vessels in zebrafish embryos. Notably, in a pancreatic cancer xenograft mouse model, 8a down-regulated the expression of CD31, a marker protein of angiogenesis. These findings suggest that 8a could be a promising antiangiogenic and cancer therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Laboratory for Marine Drugs and Bioproducts of Laoshan Laboratory, Qingdao 266237, China.
- College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.
ORCID-Profile: Yuchao Gu
Förderung
- the Program of National Natural Science Foundation of China
- the Program of Shandong Province Special Fund "Frontier Technology and Free Exploration" Project of Laoshan Laboratory
- the Fundamental Research Funds for the Central Universities
- the Taishan Scholars Program
- Program of the National Natural Science Foundation of China
- Qingdao Marine Science and Technology Centre
- Fundamental Research Funds for the Central Universities
- Taishan Scholars Program
Zitieren
APA
Song, N., Tang, Y., Wang, Y., Guan, X., Yu, W., Jiang, T., Lu, L., & Gu, Y. (2023). A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis. Marine Drugs. https://doi.org/10.3390/md21100517
Vancouver
Song N, Tang Y, Wang Y, Guan X, Yu W, Jiang T, et al. A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis. Marine Drugs. 2023. doi:10.3390/md21100517
BibTeX
@article{Song2023,
author = {Song, Nannan and Tang, Yanfei and Wang, Yangui and Guan, Xian and Yu, Wengong and Jiang, Tao and Lu, Ling and Gu, Yuchao},
title = {A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21100517}
}
EUVIMED